US Pharma presentation on clone screen strategy for monoclonality using Solen...IanTaylor50
Presentation by a Cell Metric CLD customer in US about their use of the system in clone screening for cell line development.
This presentation is made available courtesy of Momenta Pharmaceuticals and IBC Conferences
Latest guidance from the US FDA o the importance of clonality for mammalian cell banks. This was presented at the Cell Line Development Conference in Amsterdam, 24th April, 2017
ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...IanTaylor50
Initial data presented on the new VIPS single cell seeding technology was presented in the prestigious ESACT poster sessions in Lausanne by Dr Ian Taylor (15-17th May, 2017)
US Pharma presentation on clone screen strategy for monoclonality using Solen...IanTaylor50
Presentation by a Cell Metric CLD customer in US about their use of the system in clone screening for cell line development.
This presentation is made available courtesy of Momenta Pharmaceuticals and IBC Conferences
Latest guidance from the US FDA o the importance of clonality for mammalian cell banks. This was presented at the Cell Line Development Conference in Amsterdam, 24th April, 2017
ESACT 2017 Poster - A new cell line development platform for sigh efficiency ...IanTaylor50
Initial data presented on the new VIPS single cell seeding technology was presented in the prestigious ESACT poster sessions in Lausanne by Dr Ian Taylor (15-17th May, 2017)
Learn more about the Valitacell fluorescent polarisation based IgG quantification assay 'ValitaTITER' and about our novel ChemStress fingerprinting assay for cell line development. For more information about our products and pricing, please contact info@valitacell.com
Sharon Bahia from the European Collection of Authenticated Cell Cultures of P...OECD Environment
The OECD Test Guidelines Programme is increasingly integrating innovative methodologies for the safety testing of chemicals into regulatory standards. Ensuring transparency, broad and and fair access to these innovative methods are important principles. Recently, the OECD published Guiding Principles for Good Licensing Practices of protected elements in Test Guidelines. This webinar explained those principles and showed how they can be useful in your work. If you are from the community of test developers, this webinar video recording is for you!
Demonstrating Process Scalability with Robust and Turnkey PlatformsMilliporeSigma
Upstream bioreactor process development and scale-up is a time-consuming step in recombinant protein production. Variability in the recombinant cell, cell culture media and bioreactor vessel contributes to the number of studies required to obtain a stable, productive, and scalable process. In our laboratory, we set out to develop a robust, turnkey platform that includes DNA vectors, modified cell lines, chemically defined cell culture media and single-use bioreactors. Here we demonstrate process development and scale-up of a recombinant CHOZN® GS clone in EX-CELL® Advanced™ cell culture media from small-scale flasks through bench-scale bioreactors and up to 50 L pilot scale bioreactor systems. While challenges typical of process scale-up were present, we consistently achieved the desired level of process performance across the different scales with minimal process optimization due to the robustness of the complete solution.
In this webinar, you will learn about:
- Demonstrating the process development and scale-up of a recombinant CHOZN® GS clone in EX-CELL® Advanced™ cell culture media from small-scale up to 50 L pilot scale.
- Achieving the desired level of process performance across the different scales.
Biosafety in Gene Therapy: Applying the latest regulatory guidance for RCL te...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/33WUiqE
Ensuring the safety and quality of your lentiviral vector is of the utmost importance. Attend this webinar to learn about testing strategies to monitor replication competent lentivirus. You will also hear about recent changes in regulatory guidance with regards to sample types and volumes tested.
The use of lentivirus vectors to produce groundbreaking gene therapies is on the rise. Ensuring the biosafety and quality of these vectors is achieved through a multi-tiered testing approach.
For lentivirus-based therapies, generation of replication competent particles is a potential risk. While improvements in design and manufacturing have decreased the probability of producing replication competent viruses, regulatory agencies provide guidelines to test for their presence at multiple stages in production. This webinar reviews the strategies for monitoring replication competent lentiviruses. We describe current methods and address: Sample types, testing volumes, and expected results.
In this webinar, you will learn about:
• The latest FDA regulatory guidelines on replication competent lentivirus (RCL) testing
• Methods used to monitor RCL
• Considerations on sample type and volume requirements
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...Merck Life Sciences
This poster explores key elements of bioreactor design and automation strategies that enable successful implementation of seed train intensification via perfusion:
- Sparger performance characterization
- Cell retention device connection
- Evaluation of the Hamiltion® Incyte viable cell density (or permittivity) sensor
- Cell culture case studies
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.merckmillipore.com/mlab
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference Databasenist-spin
"Development of FDA MicroDB: A Regulatory-Grade
Microbial Reference Database" presentation at the Standards for Pathogen Identification via NGS (SPIN) workshop hosted by National Institute for Standards and Technology October 2014 by Heike Sichtig, PhD from the FDA and Luke Tallon from IGS UMSOM.
Evolving Trends in mAb Production ProcessesKBI Biopharma
Monoclonal antibodies (mAbs) have established themselves as the leading biopharmaceutical therapeutic modality. The establishment of robust manufacturing platforms are key for antibody drug discovery efforts to seamlessly translate into clinical and commercial successes. Several drivers are
influencing the design of mAb manufacturing processes. The advent of biosimilars is driving a desire to achieve lower cost of goods and globalize biologics manufacturing. High titers are now
routinely achieved for mAbs in mammalian cell culture. These drivers have resulted in significant evolution in process platform approaches. Additionally, several new trends in bioprocessing havearisen in keeping with these needs. These include the consideration of alternative expression systems, continuous biomanufacturing and non-chromatographic separation formats. This paper discusses these drivers in the context of the kinds of changes they are driving in mAb production processes.
Learn more about the Valitacell fluorescent polarisation based IgG quantification assay 'ValitaTITER' and about our novel ChemStress fingerprinting assay for cell line development. For more information about our products and pricing, please contact info@valitacell.com
Sharon Bahia from the European Collection of Authenticated Cell Cultures of P...OECD Environment
The OECD Test Guidelines Programme is increasingly integrating innovative methodologies for the safety testing of chemicals into regulatory standards. Ensuring transparency, broad and and fair access to these innovative methods are important principles. Recently, the OECD published Guiding Principles for Good Licensing Practices of protected elements in Test Guidelines. This webinar explained those principles and showed how they can be useful in your work. If you are from the community of test developers, this webinar video recording is for you!
Demonstrating Process Scalability with Robust and Turnkey PlatformsMilliporeSigma
Upstream bioreactor process development and scale-up is a time-consuming step in recombinant protein production. Variability in the recombinant cell, cell culture media and bioreactor vessel contributes to the number of studies required to obtain a stable, productive, and scalable process. In our laboratory, we set out to develop a robust, turnkey platform that includes DNA vectors, modified cell lines, chemically defined cell culture media and single-use bioreactors. Here we demonstrate process development and scale-up of a recombinant CHOZN® GS clone in EX-CELL® Advanced™ cell culture media from small-scale flasks through bench-scale bioreactors and up to 50 L pilot scale bioreactor systems. While challenges typical of process scale-up were present, we consistently achieved the desired level of process performance across the different scales with minimal process optimization due to the robustness of the complete solution.
In this webinar, you will learn about:
- Demonstrating the process development and scale-up of a recombinant CHOZN® GS clone in EX-CELL® Advanced™ cell culture media from small-scale up to 50 L pilot scale.
- Achieving the desired level of process performance across the different scales.
Biosafety in Gene Therapy: Applying the latest regulatory guidance for RCL te...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/33WUiqE
Ensuring the safety and quality of your lentiviral vector is of the utmost importance. Attend this webinar to learn about testing strategies to monitor replication competent lentivirus. You will also hear about recent changes in regulatory guidance with regards to sample types and volumes tested.
The use of lentivirus vectors to produce groundbreaking gene therapies is on the rise. Ensuring the biosafety and quality of these vectors is achieved through a multi-tiered testing approach.
For lentivirus-based therapies, generation of replication competent particles is a potential risk. While improvements in design and manufacturing have decreased the probability of producing replication competent viruses, regulatory agencies provide guidelines to test for their presence at multiple stages in production. This webinar reviews the strategies for monitoring replication competent lentiviruses. We describe current methods and address: Sample types, testing volumes, and expected results.
In this webinar, you will learn about:
• The latest FDA regulatory guidelines on replication competent lentivirus (RCL) testing
• Methods used to monitor RCL
• Considerations on sample type and volume requirements
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...Merck Life Sciences
This poster explores key elements of bioreactor design and automation strategies that enable successful implementation of seed train intensification via perfusion:
- Sparger performance characterization
- Cell retention device connection
- Evaluation of the Hamiltion® Incyte viable cell density (or permittivity) sensor
- Cell culture case studies
To learn more about this topic or collaborate with our technical experts, schedule an in-person or remote visit at our M Lab™ Collaboration Centers: www.merckmillipore.com/mlab
Development of FDA MicroDB: A Regulatory-Grade Microbial Reference Databasenist-spin
"Development of FDA MicroDB: A Regulatory-Grade
Microbial Reference Database" presentation at the Standards for Pathogen Identification via NGS (SPIN) workshop hosted by National Institute for Standards and Technology October 2014 by Heike Sichtig, PhD from the FDA and Luke Tallon from IGS UMSOM.
Evolving Trends in mAb Production ProcessesKBI Biopharma
Monoclonal antibodies (mAbs) have established themselves as the leading biopharmaceutical therapeutic modality. The establishment of robust manufacturing platforms are key for antibody drug discovery efforts to seamlessly translate into clinical and commercial successes. Several drivers are
influencing the design of mAb manufacturing processes. The advent of biosimilars is driving a desire to achieve lower cost of goods and globalize biologics manufacturing. High titers are now
routinely achieved for mAbs in mammalian cell culture. These drivers have resulted in significant evolution in process platform approaches. Additionally, several new trends in bioprocessing havearisen in keeping with these needs. These include the consideration of alternative expression systems, continuous biomanufacturing and non-chromatographic separation formats. This paper discusses these drivers in the context of the kinds of changes they are driving in mAb production processes.
Leveraging Machine Learning Techniques Predictive Analytics for Knowledge Dis...Kevin Mader
Review the basic principles of predictive analytics.
Be exposed to some of the existing validation methodologies to test predictive models.
Understand how to incorporate radiology data sources (PACS, RIS, etc) into predictive modeling
Learn how to interpret results and make visualizations.
We aim to provide useful information on COVID-19 spread at the county level while contributing new cutting edge techniques to the MLOps and AI research communities. Moreover, we hope to build an easily accessible infrastructure that others can use.
Advanced Automated Analytics Using OSS Tools, GA Tech FDA Conference 2016Grid Protection Alliance
The exponential increase in data available to analyze power system events is universally recognized, but in many cases the approach to using this data is to do what we already do but do it faster, or get more people to do it. Unfortunately, spinning the hamster wheel faster is not keeping up with the demand to make decisions faster in support of grid modernization. Open source software (OSS) tools offer tremendous opportunity for collaboration that encourages innovation, and the speed and flexibility of development to keep pace with these demands.
Predicting Patient Outcomes in Real-Time at HCASri Ambati
Data Scientist Allison Baker and Development Manager of Data Products Cody Hall work with a talented team of data scientists, software engineers, and web developers, and are building the framework and infrastructure to support a real-time prediction application, with the ability to scale across the entire company. Paramount to these efforts has been the capability of integrating the architecture for software production with the predictive models generated by H2O. This talk will review the processes by which HCA is building a pipeline to predict patient outcomes in real-time, heavily relying on H2O’s POJO scoring API and implemented in Clojure data processing. #h2ony
- Powered by the open source machine learning software H2O.ai. Contributors welcome at: https://github.com/h2oai
- To view videos on H2O open source machine learning software, go to: https://www.youtube.com/user/0xdata
As an expert provider of a wide spectrum of clinical development support services, KCR has developed
a supreme Data Management (DM) solution geared towards full data transparency as well as
delivering the highest level of quality within the defined timelines and in adherence to study budgets,
all the while ensuring the meeting of all Good Clinical Practice (GCP) and ICH requirements. Read our DM brochure and learn more about KCR DM capabilities.
Discover a completely integrated surgical imaging workflow through the use of Stryker SDC surgical cameras and DataMediatOR with Cerner Millennium. Using these tools, surgeons have an automated and secure way to capture images during procedures, and then share the images with patients and other providers. During this panel, we will discuss the value and simplicity of a surgical imaging project and provide detailed information specific to the implementation and integration of these two systems and its hardware.
Evaluating Cloud vs On-Premises for NGS Clinical WorkflowsGolden Helix
In the era where cloud-based solutions are the default for the modern office, it may not be obvious why many laboratories and testing centers choose to host their data and analysis pipelines on-premises or on self-managed cloud services. Next-generation sequencing enables a precision medicine approach to rare disease diagnostic and cancer therapeutics through its power to detect unique variants in individuals. This data is generated quickly and cheaply but requires a lot of disk space and processing power to arrive at clinically useful insights.
When providing a clinical lab service under a regulated environment: data security, long-term affordable storage, and versioning through locked-down pipelines are all factors that must go into the choice of whether to choose a hosted analytics platform versus on-premises solutions or self-managed cloud infrastructure.
Join us in this webinar as we cover:
The validation and regulatory requirements that inform infrastructure and hosting decisions for NGS labs
The cost structure of scaling NGS labs to exomes and genomes
Deployment and security architecture for on-premises and self-managed cloud infrastructure
Validating and versioning analysis pipelines with clinical tests through self-managed software lifecycles and versioned annotation sources
Cybersecurity, patient data privacy, and scalable unit economics play a bigger role than ever before in the planning of NGS lab’s infrastructure choices. We look forward to you joining us as we tackle the trade-offs and choices around these topics and how deployment flexibility is a core feature of the Golden Helix VarSeq Suite.
This presentation in mainly focused of understanding of automation and its utility in cytopathology. It will be very usefull for postgraduate in pathology, cytopathologist and cytotechnicians.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
Enhancing Performance with Globus and the Science DMZGlobus
ESnet has led the way in helping national facilities—and many other institutions in the research community—configure Science DMZs and troubleshoot network issues to maximize data transfer performance. In this talk we will present a summary of approaches and tips for getting the most out of your network infrastructure using Globus Connect Server.
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
SAP Sapphire 2024 - ASUG301 building better apps with SAP Fiori.pdfPeter Spielvogel
Building better applications for business users with SAP Fiori.
• What is SAP Fiori and why it matters to you
• How a better user experience drives measurable business benefits
• How to get started with SAP Fiori today
• How SAP Fiori elements accelerates application development
• How SAP Build Code includes SAP Fiori tools and other generative artificial intelligence capabilities
• How SAP Fiori paves the way for using AI in SAP apps
Le nuove frontiere dell'AI nell'RPA con UiPath Autopilot™UiPathCommunity
In questo evento online gratuito, organizzato dalla Community Italiana di UiPath, potrai esplorare le nuove funzionalità di Autopilot, il tool che integra l'Intelligenza Artificiale nei processi di sviluppo e utilizzo delle Automazioni.
📕 Vedremo insieme alcuni esempi dell'utilizzo di Autopilot in diversi tool della Suite UiPath:
Autopilot per Studio Web
Autopilot per Studio
Autopilot per Apps
Clipboard AI
GenAI applicata alla Document Understanding
👨🏫👨💻 Speakers:
Stefano Negro, UiPath MVPx3, RPA Tech Lead @ BSP Consultant
Flavio Martinelli, UiPath MVP 2023, Technical Account Manager @UiPath
Andrei Tasca, RPA Solutions Team Lead @NTT Data
Essentials of Automations: The Art of Triggers and Actions in FMESafe Software
In this second installment of our Essentials of Automations webinar series, we’ll explore the landscape of triggers and actions, guiding you through the nuances of authoring and adapting workspaces for seamless automations. Gain an understanding of the full spectrum of triggers and actions available in FME, empowering you to enhance your workspaces for efficient automation.
We’ll kick things off by showcasing the most commonly used event-based triggers, introducing you to various automation workflows like manual triggers, schedules, directory watchers, and more. Plus, see how these elements play out in real scenarios.
Whether you’re tweaking your current setup or building from the ground up, this session will arm you with the tools and insights needed to transform your FME usage into a powerhouse of productivity. Join us to discover effective strategies that simplify complex processes, enhancing your productivity and transforming your data management practices with FME. Let’s turn complexity into clarity and make your workspaces work wonders!
Elevating Tactical DDD Patterns Through Object CalisthenicsDorra BARTAGUIZ
After immersing yourself in the blue book and its red counterpart, attending DDD-focused conferences, and applying tactical patterns, you're left with a crucial question: How do I ensure my design is effective? Tactical patterns within Domain-Driven Design (DDD) serve as guiding principles for creating clear and manageable domain models. However, achieving success with these patterns requires additional guidance. Interestingly, we've observed that a set of constraints initially designed for training purposes remarkably aligns with effective pattern implementation, offering a more ‘mechanical’ approach. Let's explore together how Object Calisthenics can elevate the design of your tactical DDD patterns, offering concrete help for those venturing into DDD for the first time!
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfPaige Cruz
Monitoring and observability aren’t traditionally found in software curriculums and many of us cobble this knowledge together from whatever vendor or ecosystem we were first introduced to and whatever is a part of your current company’s observability stack.
While the dev and ops silo continues to crumble….many organizations still relegate monitoring & observability as the purview of ops, infra and SRE teams. This is a mistake - achieving a highly observable system requires collaboration up and down the stack.
I, a former op, would like to extend an invitation to all application developers to join the observability party will share these foundational concepts to build on:
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionAggregage
Join Maher Hanafi, VP of Engineering at Betterworks, in this new session where he'll share a practical framework to transform Gen AI prototypes into impactful products! He'll delve into the complexities of data collection and management, model selection and optimization, and ensuring security, scalability, and responsible use.
The Metaverse and AI: how can decision-makers harness the Metaverse for their...Jen Stirrup
The Metaverse is popularized in science fiction, and now it is becoming closer to being a part of our daily lives through the use of social media and shopping companies. How can businesses survive in a world where Artificial Intelligence is becoming the present as well as the future of technology, and how does the Metaverse fit into business strategy when futurist ideas are developing into reality at accelerated rates? How do we do this when our data isn't up to scratch? How can we move towards success with our data so we are set up for the Metaverse when it arrives?
How can you help your company evolve, adapt, and succeed using Artificial Intelligence and the Metaverse to stay ahead of the competition? What are the potential issues, complications, and benefits that these technologies could bring to us and our organizations? In this session, Jen Stirrup will explain how to start thinking about these technologies as an organisation.
Removing Uninteresting Bytes in Software FuzzingAftab Hussain
Imagine a world where software fuzzing, the process of mutating bytes in test seeds to uncover hidden and erroneous program behaviors, becomes faster and more effective. A lot depends on the initial seeds, which can significantly dictate the trajectory of a fuzzing campaign, particularly in terms of how long it takes to uncover interesting behaviour in your code. We introduce DIAR, a technique designed to speedup fuzzing campaigns by pinpointing and eliminating those uninteresting bytes in the seeds. Picture this: instead of wasting valuable resources on meaningless mutations in large, bloated seeds, DIAR removes the unnecessary bytes, streamlining the entire process.
In this work, we equipped AFL, a popular fuzzer, with DIAR and examined two critical Linux libraries -- Libxml's xmllint, a tool for parsing xml documents, and Binutil's readelf, an essential debugging and security analysis command-line tool used to display detailed information about ELF (Executable and Linkable Format). Our preliminary results show that AFL+DIAR does not only discover new paths more quickly but also achieves higher coverage overall. This work thus showcases how starting with lean and optimized seeds can lead to faster, more comprehensive fuzzing campaigns -- and DIAR helps you find such seeds.
- These are slides of the talk given at IEEE International Conference on Software Testing Verification and Validation Workshop, ICSTW 2022.
Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...SOFTTECHHUB
The choice of an operating system plays a pivotal role in shaping our computing experience. For decades, Microsoft's Windows has dominated the market, offering a familiar and widely adopted platform for personal and professional use. However, as technological advancements continue to push the boundaries of innovation, alternative operating systems have emerged, challenging the status quo and offering users a fresh perspective on computing.
One such alternative that has garnered significant attention and acclaim is Nitrux Linux 3.5.0, a sleek, powerful, and user-friendly Linux distribution that promises to redefine the way we interact with our devices. With its focus on performance, security, and customization, Nitrux Linux presents a compelling case for those seeking to break free from the constraints of proprietary software and embrace the freedom and flexibility of open-source computing.
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
2. Needs
• FDA requirements for image documentation (reference -Sarah Kennett)
• Image of the entire well needed
• Is there 1 cell or 2 cell at Day 0
• Single colony image not sufficient (single cell image needed)
• This proof data is needed as part of IND and BLA for biologicals and
biosimilars
• Current customer methods
• Manual with customers currently cutting, pasting & annotating image data
• No standard formats
• Loss of audit trail
• Takes a long time to put together
3. Clonality Report
• Report function within the Cell Metric CLD software for creation and publication
of a clonality report.
• This report tracks all growth time points for a given well containing vital
information such as a single cell loci, cell division, colony growth, plate debris or
artefacts and other features of interest.
• Free of charge upgrade for existing users
4. The ability to go back in time - Recommended order of
image review
• Day 14 (approx.)
• Scan to identify wells with good growth characteristics (% confluence)
• Day 7
• Intermediate scan to identify number of colony loci growing in a well
• Day 0
• Post seeding image review of only the wells showing desired growth characteristics. Choose
based on external productivity data and viability data combined with confluence data from
day 14 and loci information from day 7. look for single cell in the well
• Pre-scan to capture images of wells before seeding to identify debris
• Day 1
• Confirm single cell at day 0 is now two cells
• Day 2
• Two cells should now be four cells (based on binary divisions of both cells)
5. Features of report page
• Generated from ‘within’ the Cell Metric software, no cutting and
pasting
• Timeline of selected time points as whole well thumbnails
• One time point = one page of report
• Zoomed in on features of interest
• Main Feature is single cell locus
• Fully user-editable naming and annotation of features – cells, debris,
other
• Minutes (rather than days) to compile this report
6.
7.
8.
9.
10. Practical Notes
• Cell Metric CLD has the advantage that 100% of the wells are always
in focus (regardless of whether cells are present)
• Where some of our customers use FACS to dispense cells into culture
media, they do a pre-scan image of plates + media (before cells
added)
• The pre-scan time point can then included in the clonality report
• This is a rapid way to eliminate debris and artefacts as they were
present before the cell was added
11. Practical Notes
• Useful to use the high resolution “verify clonality” imaging mode on
Day 0, 1, 2 to see single cell and then audit initial binary divisions:
- 1 cell becomes 2 cells
- 2 cells become 4 cells
- Odd numbers at this early stage are a warning sign
• Additionally want to see a single colony outgrowth forms from a
single cell progenitor
12. Format of the report
• Output in Powerpoint, PDF or Print
• Can be generated at the PC terminal of the Cell Metric or elsewhere
using remote data viewer software option
• Takes minutes rather than hours or days to generate
13. Existing Pharma customer poster at ESACT
2015 – testimonial (ref)
‘This report function enables the operator an exportable
option which is “proof that can travel” in paper reports,
electronic files and presentation’
14. References
• “Establishing clonal cell lines – a regulatory perspective” Sarah Kennett,
FDA, 2014
• Cell (CHOZN) image data courtesy of SAFC Bioscience
• ESACT 2015 poster # P-1.69 “Implementation of new methods for single
cell sorting and plate imaging results in an improved cell line
development platform for biologics development” Cairns et al. (Sanofi)